(Q37849394)

24 August 2017

1 reference

title

Population biological principles of drug-resistance evolution in infectious diseases (English)

1 reference

24 August 2017

1 reference

5

1 reference

24 August 2017

Pia Abel zur Wiesch

1

0 references

Roger Kouyos

object named as

Roger Kouyos

series ordinal

2

0 references

author name string

Jan Engelstädter

series ordinal

3

1 reference

PubMed ID

21371657

24 August 2017

Roland R Regoes

series ordinal

4

1 reference

24 August 2017

1 March 2011

1 reference

Lancet Infectious Diseases

24 August 2017

1 reference

24 August 2017

11

1 reference

24 August 2017

3

1 reference

24 August 2017

236-247

1 reference

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Economic consequences of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Bacteriophage types in penicillin-resistant staphylococcal infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Epidemiology of drug-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Production of resistant HIV mutants during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Quantitative image analysis of HIV-1 infection in lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Stochastic or deterministic: what is the effective population size of HIV-1?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Meningococcal bacterial DNA load at presentation correlates with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The de novo selection of drug-resistant malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

1 reference

7 January 2021

Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Variations in frequencies of drug resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Homologous recombination is very rare or absent in human influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Homologous recombination is unlikely to play a major role in influenza B virus evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The evolutionary genomics of pathogen recombination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Drug resistance models for malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Stable association between strains of Mycobacterium tuberculosis and their human host populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Saturation and base composition bias explain phylogenomic conflict in Plasmodium.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The origin and global emergence of adamantane resistant A/H3N2 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

First cases of spread of oseltamivir resistant swine flu between patients are reported in Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Evolutionary biology and the avoidance of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Antimalarial drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Inactivation of influenza A viruses in the environment and modes of transmission: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Health-care workers: source, vector, or victim of MRSA?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Clinical practice. Prevention and treatment of seasonal influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

A stochastic model for primary HIV infection: optimal timing of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Compensation of fitness costs and reversibility of antibiotic resistance mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Reversion of resistance in relapsing infection caused by a glycopeptide-intermediate methicillin-resistant Staphylococcus aureus isolate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Static recipient cells as reservoirs of antibiotic resistance during antibiotic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Optimizing drug exposure to minimize selection of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Modelling time-kill studies to discern the pharmacodynamics of meropenem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Drug concentration heterogeneity facilitates the evolution of drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The mutant selection window in rabbits infected with Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Fluoroquinolones: action and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Preventing HIV antiretroviral resistance through better monitoring of treatment adherence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The population dynamics of antimicrobial chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Antibiotic consumption and resistance selection in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Antimicrobial use and antimicrobial resistance: a population perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Correlation between meticillin-resistant Staphylococcus aureus prevalence and infection control initiatives within southern and eastern Mediterranean hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Antibiotic cycling: more than it might seem?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Antibiotic cycling or rotation: a systematic review of the evidence of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Evaluating treatment protocols to prevent antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Benefits of using multiple first-line therapies against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The fixation probability of beneficial mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Pre-existence and emergence of drug resistance in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Virus dynamics and drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Tuberculosis: drug resistance, fitness, and strategies for global control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The evolution of drug-resistant malaria: the role of drug elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The biological cost of mutational antibiotic resistance: any practical conclusions?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The biological cost of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Fitness of drug-resistant malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Reducing the cost of resistance; experimental evolution in the filamentous fungus Aspergillus nidulans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Darwinian evolution can follow only very few mutational paths to fitter proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Return of chloroquine antimalarial efficacy in Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Adaptation to the fitness costs of antibiotic resistance in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Bacterial persistence as a phenotypic switch

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The frequency of resistant mutant virus before antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Mutation frequencies and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Mutation rate and the efficacy of antimicrobial drug treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Recombination in HIV and the evolution of drug resistance: for better or for worse?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

HIV recombination: what is the impact on antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Evidence for Positive Epistasis in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Recombination and drug resistance in HIV: Population dynamics and stochasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Molecular mechanisms of antibacterial multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The population genetics of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Factors affecting the reversal of antimicrobial-drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Linking within- and between-host dynamics in the evolutionary epidemiology of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Adherence and drug resistance: predictions for therapy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Bacterial charity work leads to population-wide resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Molecular and evolutionary bases of within-patient genotypic and phenotypic diversity in Escherichia coli extraintestinal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Non-inherited antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Exploring the role of the immune response in preventing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

HIV therapy: managing resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Clinically immune hosts as a refuge for drug-sensitive malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Functional characterization of the antibiotic resistance reservoir in the human microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Costs versus benefits: best possible and best practical treatment regimens for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Upgrading antibiotic use within a class: tradeoff between resistance and treatment success

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Strategic interactions in multi-institutional epidemics of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Antimalarial dosing regimens and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Emergence of drug-resistant influenza virus: population dynamical considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

Allograft theory: transmission of devil facial-tumour disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970264-4

7 January 2021

10.1016/S1473-3099(10)70264-4

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21371657